Nomex (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Nomex, is an imidazoline nasal decongestant presented as a nasal spray for topical nasal use. It relieves nasal congestion associated with the common cold, sinusitis and allergic rhinitis in adults and children. It works by constricting blood vessels in the nasal mucosa, thereby decreasing swelling and improving airflow.

GNH USA supplies Nomex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch.

Xylometazoline Hydrochloride is used as a topical nasal decongestant to relieve swelling of the nasal passages. - Common cold nasal congestion: reduces swelling and improves airflow during acute viral upper respiratory infection. - Sinusitis-related congestion: alleviates blockage associated with sinus inflammation, facilitating drainage. - Allergic rhinitis: relieves nasal congestion caused by allergic reactions, supporting better breathing.

Nasal application of Xylometazoline Hydrochloride may be associated with local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of nasal mucosa - Sneezing - Headache

Serious or Rare Side Effects: - Severe hypertension - Nasal ulceration or necrosis - Anaphylactic reaction - Rebound congestion (rhinitis medicamentosa) after prolonged use

Before using Nomex, consider the following safety points. - Pregnancy: safety not established; use only if clearly needed. - Children: follow age‑specific labeling; avoid use in infants under 2 years. - Cardiovascular disease: use with caution in patients with hypertension or heart disease. - Concomitant sympathomimetic drugs: avoid combined use to prevent excessive vasoconstriction. - Duration of use: limit to 3‑5 days to reduce risk of rebound congestion. - Store at room temperature: keep in original container, protect from moisture and heat.

Xylometazoline Hydrochloride can interact with other medicines.

Major Interactions (Avoid): - Monoamine oxidase inhibitors: may cause hypertensive crisis. - Other nasal decongestants: additive vasoconstriction increases risk of ischemia. - Systemic sympathomimetics (e.g., pseudoephedrine): heightened cardiovascular effects.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: possible reduction in blood pressure control. - Beta‑blockers: may blunt compensatory heart rate response. - Tricyclic antidepressants: potential additive sympathomimetic activity.